Axogen, Inc. — Director's Dealing 2011

Dec 28, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-12-26

Reporting Person: Freitag Gregory Gene (Director, CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-26	Employee Stock Option (right to buy)	$2.74	A	92000	Acquired	2018-12-26	Common Stock (92000)	Direct

Footnotes

F1: All shares pursuant to the options will be fully vested on December 26, 2015 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 26, 2012 (12 months from the option grant date) and an additional 12.5% of aggregate shares each 6 months thereafter.